Targeted Delivery of Cordycepin to Liver Cancer Cells Using Transferrin-conjugated Liposomes
Cordycepin
Nanocarriers
Transferrin receptor
DOI:
10.21873/anticanres.11944
Publication Date:
2017-09-06T21:23:45Z
AUTHORS (7)
ABSTRACT
Background/Aim: Cordycepin is an endogenous nucleoside with significant anticancer biological activity. The objective of this study was to develop targeted liposomes improve solubility and activity cordycepin. Materials Methods: We established transferrin-conjugated deliver cordycepin liver cancer cells evaluated the uptake effect. Results: were loaded Their average size 125.3 nm, drug encapsulation efficiency 65.3%. had good colloidal stability released slowly. Liposomal shown increase reactive oxygen species production cause depolarization mitochondrial transmembrane in cells. Cellular liposomal enhanced by conjugation transferrin, that facilitated receptor-mediated endocytosis. Conclusion: Transferrin-conjugated are effective as nanocarriers for delivery
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (5)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....